Counterfeit and Grey-Market Injectables: How to Spot Them and Why They Matter

As aesthetic treatments have boomed, so has a shadow market of counterfeit and grey-market products — fake toxins, unlicensed fillers and medicines diverted outside the proper supply chain. For a clinic, these are not a bargain; they are a serious risk to patient safety, to your reputation, and increasingly to your liberty, as authorities crack down hard on illegal supply.

Understand what you are dealing with

Counterfeit products are outright fakes — imitations passed off as genuine, with unknown and potentially dangerous contents. Grey-market products may be genuine but have been imported or diverted outside the authorised channel, meaning their storage, handling and provenance cannot be assured. Both bypass the safeguards that make legitimate products safe, and both put whatever they contain into your patient.

Know why it matters

With a fake or improperly handled product, you have no guarantee of what is in the vial, whether it has been stored correctly, or whether it is sterile. Patients have been harmed by counterfeit toxins and fillers, and the MHRA has pursued and prosecuted those supplying illegal medicines, including custodial sentences. Using such products can expose you to criminal liability, invalidate your insurance and end your career — quite apart from the harm to the patient in your chair.

Spot the warning signs

Grey and counterfeit supply tends to share tells: prices well below the going rate; sellers operating through social media or informal messaging rather than proper trade accounts; packaging or labelling that looks subtly wrong; missing batch information; foreign-market packaging on a supposedly UK-supplied product; and pressure to buy quickly. Any one of these should give you pause; several together are a clear signal to walk away.

Protect yourself and your patients

The defence is simple: buy only from reputable, verifiable suppliers operating through proper channels, insist on traceability, and never let price tempt you off that path. If you are ever offered product that seems too cheap or too easy, treat that as information in itself. And if you suspect a product is falsified, report it to the MHRA rather than quietly returning it — you may be protecting other clinics and patients too.

The stakes are only rising

Enforcement is tightening, not loosening. As regulation of the sector increases, so does the scrutiny of where clinics obtain their products. A supply chain you can evidence is fast becoming not just good practice but an expectation — one more reason to make responsible sourcing a firm, non-negotiable policy now rather than later.

There is no safe way to use an unsafe product. Sourcing responsibly is not the expensive option; it is the only option that protects your patients, your practice and your future.